About Ablative Solutions
Ablative Solutions is a company based in Kalamazoo (United States) founded in 2011. Ablative Solutions has raised $303.65 million across 13 funding rounds from investors including Novus Life Sciences, Gilde Healthcare and Invus. The company has 24 employees as of December 31, 2022. Ablative Solutions offers products and services including Peregrine System. Ablative Solutions operates in a competitive market with competitors including ReCor Medical, Brattea, Autonomix, Kalos Medical and Maya Medical, among others.
- Headquarter Kalamazoo, United States
- Employees 24 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ablative Solutions Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$303.65 M (USD)
in 13 rounds
-
Latest Funding Round
$10.41 M (USD), Series D
Nov 14, 2025
-
Investors
Novus Life Sciences
& 5 more
-
Employee Count
24
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ablative Solutions
Ablative Solutions offers a comprehensive portfolio of products and services, including Peregrine System.
Investigational kit for renal denervation to treat hypertension in clinical trials
People of Ablative Solutions
Unlock access to complete
Unlock access to complete
Funding Insights of Ablative Solutions
Ablative Solutions has successfully raised a total of $303.65M across 13 strategic funding rounds. The most recent funding activity was a Series D round of $10.41 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ablative Solutions
Ablative Solutions has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Novus Life Sciences, Gilde Healthcare and Invus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture captial firm focused on healthcare sectors
|
Locked | Locked | Locked | |
|
Long-term private equity investments in transformational opportunities are pursued.
|
Locked | Locked | Locked | |
|
Healthtech startups are funded by BioStar Capital's venture capital efforts.
|
Locked | Locked | Locked |
Investor details for Ablative Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ablative Solutions
Investment portfolio details for Ablative Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ablative Solutions
Detailed financials for Ablative Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ablative Solutions Comparisons
Peer comparison for Ablative Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ablative Solutions
Ablative Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ReCor Medical, Brattea, Autonomix, Kalos Medical and Maya Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ultrasound-based renal denervation is applied for hypertension treatment.
|
|
| Locked | Locked | Locked |
Developer of a medical device for the treatment of hypertension
|
|
| Locked | Locked | Locked |
Minimally invasive neural monitoring and treatment devices are developed.
|
|
| Locked | Locked | Locked |
Developer of medical devices for the treatment of hypertension & other chronic diseases
|
|
| Locked | Locked | Locked |
Catheter based ablative technology for renal denervation to treat hypertension
|
Detailed competitors of Ablative Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ablative Solutions
Complete news archive for Ablative Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ablative Solutions
Ablative Solutions was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Ablative Solutions is headquartered in Kalamazoo, United States. It is registered at Kalamazoo, Michigan, United States.
Ablative Solutions is a funded company, having raised a total of $303.65M across 13 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Ablative Solutions is 24.
Ablative Solutions was founded in 2011 and is located in Kalamazoo, United States. Renal denervation technologies are developed by the company within the medical device sector to address hypertension. A catheter-based method is used to deliver diagnostic and therapeutic agents to the perivascular space around peripheral blood vessels. The Peregrine system is being evaluated clinically for hypertension management. Operations focus on interventional cardiology solutions.
Ablative Solutions's top competitors include ReCor Medical, Autonomix and Maya Medical.
Ablative Solutions offers Peregrine System.
Ablative Solutions has 6 investors. Key investors include Novus Life Sciences, Gilde Healthcare, Invus, BioStar Capital, and Charter Capital Partners.